Indication

Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

1 clinical trial

1 product

Clinical trial

Phase 1 Study of CD30-Directed Genetically Modified Autologous T-Cells (CD30.CAR-T) in Patients With Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Status: Active (not recruiting), Estimated PCD: 2022-11-22

Product